Bristol-Myers Squibb Co (NYSE:BMY)
$ 55 -0.53 (-0.95%) Market Cap: 112.31 Bil Enterprise Value: 148.29 Bil PE Ratio: 15.45 PB Ratio: 5.60 GF Score: 77/100

Bristol-Myers Squibb Co at TD Cowen Healthcare Conference Transcript

Mar 02, 2026 / 02:50PM GMT
Release Date Price: $62.34 (-0.05%)
Steve Scala
Cowen and Company LLC - Analyst

Well, good morning, once again, and welcome to TD Cowen's 46th Annual Healthcare Conference. We are absolutely delighted to have Bristol-Myers Squibb here again with us this year, representing the company, Adam Lenkowsky, who is Executive Vice President and Chief Commercial Officer.

So Adam, thank you so much for being here.

Adam Lenkowsky
Bristol-Myers Squibb Co - Executive Vice President, Chief Commercialization Officer

Thanks for having me, Steve.

Questions & Answers

Steve Scala
Cowen and Company LLC - Analyst

So let's start out with a bit of a big picture. Can you remind us of any notable pushes and pulls throughout the year in terms of both revenue and OpEx we should be considering?

Adam Lenkowsky
Bristol-Myers Squibb Co - Executive Vice President, Chief Commercialization Officer

Yes, happy to do that. When I take a step back, when you think about 2025 performance, we delivered strong performance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot